KATIE RUIZ: Open Payments
NPI 1295219384 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 39 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $326 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $190 |
| Medtronic, Inc. | 3 | $88 |
| ABBVIE INC. | 4 | $86 |
| Insulet Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Ascendis Pharma Endocrinology Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| Tandem Diabetes Care, Inc. | 2 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
Products named: MINIMED 780G, Ozempic, Omnipod, Wegovy, MOUNJARO, Yorvipath, JARDIANCE, REPATHA.
Industry payments across PA — which companies pay providers there.
